A science laboratory creates an End of Life practice for their IT infrastructure using a comprehensive business analysis.
Our client had severely outdated technical systems within their applications and broader IT which posed a threat of future costs if not properly addressed. They were reviewing over 100 applications to determine the best path forward for modernizing, sunsetting, and migrating these applications. They needed help assessing their IT End of Life (EOL) landscape and developing an EOL program to account for technology interdependencies, risks, and cost estimates. The EOL process would cover Windows and Linux operating systems, vendor software, web servers, and databases. The primary objective was to review and streamline the EOL process for the client’s IT systems and maintain a secure and stable infrastructure.
Reduced Support Costs by Over $100,000
For phase one, the Apex team conducted a comprehensive assessment of the current IT infrastructure to identify systems that are approaching end of life and coordinate with client stakeholders to document a transition plan. The team also conducted a risk assessment and provided a mitigation plan. They are also responsible for ensuring that all plans for new systems can be fully integrated into the client’s existing infrastructure and meet the organization's IT security policies and standards.
In phase two, the team will conduct a comprehensive business impact analysis with client stakeholders. Then they will refine the prioritization process to include the new data sets to ensure focus on the highest-value work, factoring in the business impact. The team will complete the project with a review of and recommendations for the client’s strategy for maintaining systems including a final report to client leadership.
Apex’s plan to consolidate and modernize the client’s infrastructure led to reducing support costs by over $100,000 and eliminating 35 legacy applications. Additionally, the client now has an established practice for their EOL program. The project is still ongoing and is expected to achieve additional results.